ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET
RANCHO CORDOVA, Calif., May 15, 2023 /PRNewswire/ — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2023 and provided a corporate strategic update.
Related news for (THMO)
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
- ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
- ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference